HUMA

Humacyte Inc Cross-source read
Health CareCUSIP 44486Q103

Among active 13F managers last quarter, 17 opened and 15 added, while 9 reduced; the largest holder to move was Antipodes Partners Ltd (+77%). Over the last 180 days, 3 insiders bought and 2 insiders sold, a net +$2K in open-market trades.

Tracked 13F holders
158
13F value (tracked)
$50.5M
Smart-money readBullish
Net sellingNet buying
Funds · active managers, latest 13F
32 adding · 9 trimming
Insiders · Form 4 open-market, 180d
3 buying · 2 selling · +$2K
US House · STOCK Act, 180d
0 buying · 0 selling

Funds lean in and no leg opposes.

Who owns HUMA?

158 tracked 13F filers · ranked by shares held

158 tracked 13F filers disclose a position in HUMA as of the latest SEC 13F filings, a combined $50.5M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1Vanguard Capital Management LLC10.1M
$7.9M
+41%
Added · +2.9M sh
Q2 2026
2Antipodes Partners Ltd10.1M
$7.9M
+77%
Added · +4.4M sh
Q2 2026
3Alyeska Investment Group, L.P.6.0M
$4.7M
New
+6.0M sh
Q2 2026
4Davidson Kempner Capital Management LP5.0M
$3.9M
New
+5.0M sh
Q2 2026
5BlackRock, Inc.4.8M
$3.8M
−61%
Reduced · −7.5M sh
Q2 2026
6Great Point Partners LLC3.8M
$2.9M
Held
Q2 2026
7UBS Group AG2.8M
$1.7M
−6.6%
Reduced · −197K sh
Q1 2026
8Geode Capital Management, LLC2.2M
$1.7M
−40%
Reduced · −1.5M sh
Q2 2026
9AQR Capital Management LLC1.9M
$1.2M
57×
Added · +1.9M sh
Q1 2026
10Citadel Advisors LLC1.4M
$1.1M
Added
Added · +1.4M sh
Q2 2026
11Charles Schwab Investment Management Inc1.3M
$783K
+4.2%
Added · +52K sh
Q1 2026
12Northern Trust Corp1.2M
$743K
+6.7%
Added · +77K sh
Q1 2026
13Vanguard Fiduciary Trust Co1.2M
$921K
+17%
Added · +170K sh
Q2 2026
14Susquehanna International Group, LLP1.1M
$642K
+4.8%
Added · +48K sh
Q1 2026
15Private Advisor Group, LLC965K
$753K
+16%
Added · +132K sh
Q2 2026
16LPL Financial LLC864K
$524K
+3.2%
Added · +27K sh
Q1 2026
17State Street Corp843K
$658K
−72%
Reduced · −2.2M sh
Q2 2026
18HBK Investments L P790K
$617K
New
+790K sh
Q2 2026
19Wealth Effects LLC694K
$542K
+239%
Added · +489K sh
Q2 2026
20Goldman Sachs Group Inc677K
$411K
+58%
Added · +250K sh
Q1 2026
21Vanguard Portfolio Management LLC569K
$443K
−60%
Reduced · −849K sh
Q2 2026
22Woodline Partners LP501K
$391K
−75%
Reduced · −1.5M sh
Q2 2026
23Ghisallo Capital Management LLC500K
$390K
New
+500K sh
Q2 2026
24Aster Capital Management (DIFC) Ltd422K
$330K
New
+422K sh
Q2 2026
25XTX Topco Ltd412K
$250K
−37%
Reduced · −239K sh
Q1 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is HUMA being bought or sold by institutions?

Last quarter, 17 funds opened a new position in HUMA and 15 added to an existing one, while 9 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened
17
funds took a first position
Added
15
added to an existing position
Reduced
9
reduced, still holding
Biggest moves · ranked by size of the change, positions above a floor

Insider activity (Form 4)

Full insider page →
Buys · 180d
$85K
3 insiders
Sells · 180d
$82K
2 insiders
Net · 180d
$2K
6 open-market transactions
DateInsiderRoleActionSharesValue
Aug 20, 2026Jones Keith AnthonyDirectorBuy (P)10K$7K
Aug 17, 2026Jones Keith AnthonyDirectorBuy (P)30K$18K
May 19, 2026Sebelius KathleenDirectorBuy (P)57K$50K
May 18, 2026Sander Dale A.CFO and Chief Corp. Dev. OffSell (S)46K$41K
May 18, 2026Constantino Michael T.DirectorBuy (P)11K$10K
May 18, 2026Parikh Shamik JChief Medical OfficerSell (S)46K$41K
Aug 20, 2025Niklason Laura EPresident, CEO and Director, DirectorSell (S)592K$935K
Aug 20, 2025Dougan Brady WDirectorSell (S)592K$935K
Aug 19, 2025Niklason Laura EPresident, CEO and Director, DirectorSell (S)1.1M$1.8M
Aug 19, 2025Dougan Brady WDirectorSell (S)1.1M$1.8M
Aug 18, 2025Dougan Brady WDirectorSell (S)549K$1.0M
Aug 18, 2025Niklason Laura EPresident, CEO and Director, DirectorSell (S)549K$1.0M

Do institutions, insiders and Congress agree?

Confluence: insiders and funds buying

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
3630
Insiders
Form 4 open-market
32+$2K
US House
STOCK Act trades
00$0

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Recent filings

0 most recent

No filings captured for this ticker in the live stream yet.

Keep exploring

Connected entities for HUMA

Browse more

Build

Ask your agent what changed in HUMA

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/HUMA/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for HUMA.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + the live filing stream, joined for HUMA. Filings are public domain, sourced to SEC EDGAR.